Luckily for palmophiliacs, there’s a new show in town, and it just may change the way we think about biometric security systems.

A new biometrics system called PalmSecure, developed by Tokyo-based Fujitsu Ltd., works by matching the unique vein pattern in your palm to an infrared scan of your palm stored in a database. The system is akin to fingerprinting, but improves upon the oft-used identification system of police stations everywhere.

LONDON, June 25 /PRNewswire/ --

Cascal N.V. (NYSE: HOO) ("the Company"), a leading provider of water services in seven countries, today announced that it has filed its annual report on Form 20-F, including its audited financial statements for the fiscal year ended March 31, 2008, with the U.S. Securities and Exchange Commission (the "SEC") in accordance with United States requirements. Cascal's Form 20-F can be accessed on the Investor Relations page of the Company's website at www.cascal.co.uk, as well as on the SEC's website at www.sec.gov. Interested parties may also request a complimentary paper copy of the filing by contacting Yemi Rose, at yrose@kcsa.com.

About Cascal N.V.

LONDON, June 25 /PRNewswire/ --

- Quark Pharmaceuticals to develop drug candidate for prevention and treatment of delayed graft function in kidney transplantation

Silence Therapeutics plc (London AIM: SLN) today announces that the U.S. Food and Drug Administration (FDA) has approved a Quark Pharmaceuticals Inc ("Quark") Investigational New Drug application (IND) for an siRNA therapeutic product based on Silence's unique proprietary chemistry. The product, DGFi, was discovered and is being developed by Quark for use in kidney transplantation. Rights to the AtuRNAi structure of DGFi were licensed to Quark by Silence Therapeutics.

Energy from the sun and carbon dioxide fuel photosynthesis in plants and algae, making life on earth possible. Carbon that is fixed by plants is converted to starch and sucrose, which are utilized by plants for energy and to build biomass.

Human evolution and society have been intimately tied to our exploitation of plant biomass for food, fuel, tools, and shelter. However, to be usable, the starch carbohydrate stored in plants must be broken down to component sugars. Some aspects of starch metabolism have been known for many years, but regulation of the process and exact physical mechanisms are still not well understood.

With new information emerging from genome sequencing and mutational analyses, we are beginning to gain a better understanding of these complex and finely tuned processes. Such knowledge is especially critical as we struggle with issues of energy and food supply.

ANN ARBOR, Michigan, June 25 /PRNewswire/ --

Terumo Heart, Inc. announced today approval from the Institutional Review Board (IRB) at the University of Michigan to move forward with the DuraHeart(TM) Left Ventricular Assist System (LVAS) U.S. Pivotal Trial for a Bridge-to-Transplant (BTT) indication. Francis Pagani, M.D., Ph.D., Director of the Adult Heart Transplantation and Artificial Devices Program at the University of Michigan, will serve as the National Co-Principal Investigator of the U.S. Pivotal Trial.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU043LOGO )

REHOVOT, Israel and JERSEY CITY, New Jersey, June 25 /PRNewswire/ --

- Collaboration to Focus on the Development of MicroRNA-Based Tests for Oncology and Women's Health Indications

Rosetta Genomics, Ltd. (Nasdaq: ROSG), announced today a collaboration with the Rabin Medical Center in Israel to develop microRNA-based diagnostics in the fields of oncology, gynecology, and obstetrics. The collaboration will leverage microRNAs' significant potential as highly sensitive and specific biomarkers, to develop a wide range of diagnostic and prognostic tests. This is the company's first collaboration to include a focus on diagnostics for women's health indications.

LONDON, June 25 /PRNewswire/ --

- Arxan Technologies Expands Global Footprint to Europe to Address Software Piracy and Tampering

An international team of researchers says they have evidence of explosive volcanism in the deeps of the ice-covered Arctic Ocean for the first time.

Researchers from an expedition to the Gakkel Ridge report in the current issue of Nature that they discovered extensive layers of volcanic ash on the seafloor, which indicates a gigantic volcanic eruption.

A major part of Earth's volcanism happens at the so-called mid-ocean ridges and, therefore, completely undetected on the seafloor. There, the continental plates drift apart; liquid magma intrudes into the gap and constantly forms new seafloor through countless volcanic eruptions. Accompanied by smaller earthquakes, which go unregistered on land, lava flows onto the seafloor. These unspectacular eruptions usually last for only a few days or weeks.

MOUNTAIN VIEW, California, June 25 /PRNewswire/ --

- Demonstrates Viability of Using Mobile TV Broadcasts for positioning-based Services